Bridgefront Capital’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bridgefront Capital’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,345	Closed	-$320K	–	558
2022 Q3	$320K	Buy	+15,345	New	+$319K	0.33%	118
2021 Q3	–	Sell	-17,173	Closed	-$464K	–	736
2021 Q2	$464K	Buy	17,173 +7,837	+84%	+$219K	0.17%	198
2021 Q1	$280K	Buy	+9,336	New	+$318K	0.09%	453

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridgefront Capital's CVET Position: Q4 2022 in Review

Bridgefront Capital sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 15,345 shares — an estimated $320K sold.

Bridgefront Capital first reported a position in CVET in Q1 2021 and held it in 3 quarters. The position peaked at $464K in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Bridgefront Capital reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bridgefront Capital sold 15,345 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $320K.
Bridgefront Capital first reported a position in Covetrus, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Bridgefront Capital's Covetrus, Inc. Common Stock position peaked at $464K in Q2 2021.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Bridgefront Capital's 13F filing for Q4 2022, filed 15 Feb 2023.